784 GENES FOUNDi

Show / hide columns

XML | RDF | TSV | Page of 16 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

L1CAML1 cell adhesion moleculeCD markers
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Plasma membrane
Endometrial cancer: 8.51e-10
Lung cancer: 2.36e-6
Renal cancer: 1.17e-4
Head and neck cancer: 3.81e-4
Tissue enhanced
MBOAT2Membrane bound O-acyltransferase domain containing 2Enzymes
Predicted membrane proteins
VesiclesEndometrial cancer: 2.13e-9
Urothelial cancer: 5.32e-4
Tissue enhanced
HIF3AHypoxia inducible factor 3, alpha subunitPredicted intracellular proteins
Transcription factors
Nucleoplasm
Plasma membrane
Cytosol
Endometrial cancer: 6.90e-9
Tissue enhanced
ASS1Argininosuccinate synthase 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol
Endometrial cancer: 8.14e-9
Tissue enhanced
PTX3Pentraxin 3, longPlasma proteins
Predicted secreted proteins
Endometrial cancer: 8.35e-9
Lung cancer: 8.75e-6
Head and neck cancer: 6.36e-4
Tissue enhanced
FAM110BFamily with sequence similarity 110, member BPredicted intracellular proteins
Mitochondria
Cytosol
Endometrial cancer: 3.88e-8
Renal cancer: 4.31e-8
Pancreatic cancer: 1.44e-4
Tissue enhanced
IGSF1Immunoglobulin superfamily, member 1Disease related genes
Predicted membrane proteins
Predicted secreted proteins
CytosolEndometrial cancer: 4.25e-8
Tissue enhanced
MGAT4AMannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme AEnzymes
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatusEndometrial cancer: 6.48e-8
Breast cancer: 4.30e-4
Mixed
KHKKetohexokinase (fructokinase)Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
CytosolEndometrial cancer: 7.62e-8
Group enriched
MARK4MAP/microtubule affinity-regulating kinase 4Enzymes
Predicted intracellular proteins
Predicted membrane proteins
CytosolEndometrial cancer: 8.31e-8
Head and neck cancer: 3.05e-5
Expressed in all
GPRIN2G protein regulated inducer of neurite outgrowth 2Predicted intracellular proteins
NucleoplasmEndometrial cancer: 8.60e-8
Head and neck cancer: 3.47e-4
Tissue enhanced
ERBB2Erb-b2 receptor tyrosine kinase 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cytosol
Renal cancer: 2.41e-14
Endometrial cancer: 8.99e-8
Pancreatic cancer: 9.17e-4
Expressed in all
LMO3LIM domain only 3 (rhombotin-like 2)Predicted intracellular proteins
Endometrial cancer: 1.10e-7
Tissue enhanced
DAGLADiacylglycerol lipase, alphaDisease related genes
Predicted membrane proteins
Endometrial cancer: 1.13e-7
Tissue enriched
ADAAdenosine deaminaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Renal cancer: 2.94e-14
Endometrial cancer: 1.23e-7
Liver cancer: 6.77e-5
Lung cancer: 2.20e-4
Tissue enriched
MAP1LC3CMicrotubule-associated protein 1 light chain 3 gammaPredicted intracellular proteins
Cytoplasmic bodiesEndometrial cancer: 1.34e-7
Tissue enhanced
CDKN2ACyclin-dependent kinase inhibitor 2ACancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
NucleoliEndometrial cancer: 1.82e-7
Renal cancer: 5.76e-7
Liver cancer: 2.17e-4
Head and neck cancer: 5.19e-4
Mixed
RNF44Ring finger protein 44Predicted intracellular proteins
NucleoplasmEndometrial cancer: 2.57e-7
Liver cancer: 8.45e-4
Expressed in all
LRRN2Leucine rich repeat neuronal 2Predicted membrane proteins
Endoplasmic reticulumEndometrial cancer: 2.59e-7
Tissue enhanced
TRIM46Tripartite motif containing 46Predicted intracellular proteins
Intermediate filaments
Cytosol
Endometrial cancer: 2.61e-7
Tissue enhanced
ARL4CADP-ribosylation factor-like 4CPredicted intracellular proteins
Plasma membrane
Cytosol
Renal cancer: 3.69e-8
Endometrial cancer: 2.90e-7
Urothelial cancer: 6.99e-5
Mixed
NUAK2NUAK family, SNF1-like kinase, 2Enzymes
Predicted membrane proteins
Nucleus
Nucleoli fibrillar center
Cytosol
Endometrial cancer: 3.01e-7
Pancreatic cancer: 7.94e-6
Mixed
ARXAristaless related homeoboxDisease related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
Endometrial cancer: 3.54e-7
Tissue enriched
GGHGamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)Enzymes
Plasma proteins
Predicted secreted proteins
Endometrial cancer: 3.99e-7
Lung cancer: 1.65e-4
Tissue enhanced
CXXC5CXXC finger protein 5Predicted intracellular proteins
Nucleoplasm
Cytosol
Endometrial cancer: 4.10e-7
Colorectal cancer: 2.40e-4
Expressed in all
XPO5Exportin 5Predicted intracellular proteins
Transporters
NucleoplasmLiver cancer: 3.98e-8
Endometrial cancer: 4.94e-7
Expressed in all
PRELID3APRELI domain containing 3APredicted intracellular proteins
Endometrial cancer: 5.89e-7
Mixed
GRB7Growth factor receptor-bound protein 7Cancer-related genes
Predicted intracellular proteins
Plasma membraneEndometrial cancer: 6.60e-7
Renal cancer: 8.23e-5
Ovarian cancer: 3.10e-4
Pancreatic cancer: 6.90e-4
Mixed
SIRT2Sirtuin 2Cancer-related genes
Predicted intracellular proteins
Nucleus
Nucleoli
Cytosol
Endometrial cancer: 7.20e-7
Expressed in all
MRPS5Mitochondrial ribosomal protein S5Predicted intracellular proteins
Ribosomal proteins
MitochondriaEndometrial cancer: 7.98e-7
Liver cancer: 7.73e-5
Thyroid cancer: 6.36e-4
Expressed in all
TUBB4ATubulin, beta 4A class IVaDisease related genes
Plasma proteins
Predicted intracellular proteins
MicrotubulesEndometrial cancer: 8.42e-7
Tissue enhanced
BEX2Brain expressed X-linked 2Predicted intracellular proteins
Renal cancer: 3.05e-13
Endometrial cancer: 8.54e-7
Lung cancer: 1.52e-4
Tissue enhanced
DOK5Docking protein 5Predicted intracellular proteins
Focal adhesion sitesEndometrial cancer: 8.99e-7
Tissue enhanced
AKT2V-akt murine thymoma viral oncogene homolog 2Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nucleus
Vesicles
Cytosol
Endometrial cancer: 1.05e-6
Prostate cancer: 4.74e-4
Expressed in all
C2orf68Chromosome 2 open reading frame 68Predicted intracellular proteins
Nucleus
Nuclear membrane
Nucleoli
Mitochondria
Renal cancer: 1.11e-6
Endometrial cancer: 1.12e-6
Liver cancer: 6.76e-6
Expressed in all
ZC3H8Zinc finger CCCH-type containing 8Predicted intracellular proteins
Transcription factors
Nucleoplasm
Nuclear bodies
Endometrial cancer: 1.12e-6
Renal cancer: 1.89e-4
Expressed in all
FOXP4Forkhead box P4Predicted intracellular proteins
Transcription factors
Nucleoplasm
Cytosol
Endometrial cancer: 1.17e-6
Liver cancer: 9.72e-4
Expressed in all
CHODLChondrolectinPredicted intracellular proteins
Predicted membrane proteins
Endometrial cancer: 1.18e-6
Tissue enhanced
CHCHD7Coiled-coil-helix-coiled-coil-helix domain containing 7Cancer-related genes
Disease related genes
Predicted intracellular proteins
Cell Junctions
Aggresome
Endometrial cancer: 1.39e-6
Renal cancer: 9.47e-5
Expressed in all
PLXNA4Plexin A4Predicted membrane proteins
Predicted secreted proteins
Endometrial cancer: 1.61e-6
Tissue enhanced
ACTL8Actin-like 8Predicted intracellular proteins
CytosolEndometrial cancer: 1.62e-6
Head and neck cancer: 7.02e-4
Tissue enriched
SFTPBSurfactant protein BDisease related genes
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Endometrial cancer: 1.71e-6
Renal cancer: 2.99e-6
Tissue enriched
RECQL5RecQ helicase-like 5Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Cytosol
Endometrial cancer: 1.73e-6
Pancreatic cancer: 4.34e-4
Expressed in all
GGCXGamma-glutamyl carboxylaseDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Endometrial cancer: 1.82e-6
Expressed in all
MAP2Microtubule-associated protein 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoli
Cytosol
Endometrial cancer: 1.98e-6
Tissue enriched
SPDYE3Speedy/RINGO cell cycle regulator family member E3Predicted intracellular proteins
Endometrial cancer: 2.00e-6
Breast cancer: 8.73e-4
Tissue enriched
CAPN5Calpain 5Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleus
Cytosol
Endometrial cancer: 2.16e-6
Mixed
SAMD4BSterile alpha motif domain containing 4BPredicted intracellular proteins
CytosolEndometrial cancer: 2.17e-6
Expressed in all
CLDN9Claudin 9Predicted membrane proteins
Vesicles
Cell Junctions
Endometrial cancer: 2.24e-6
Stomach cancer: 4.67e-4
Tissue enhanced
SIMC1SUMO-interacting motifs containing 1Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center
Endometrial cancer: 2.32e-6
Glioma: 1.41e-4
Tissue enhanced

Page of 16 | next »